Ricolinostat Clinical Study - Rocky Mountain Clinical Research

Type of Study:
Interventional, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

Study Length:
28 Days

Target Age/Sex:
18 Years and older

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Staus: Enrolling

Description:

This is a randomized, double-blind, parallel group clinical study designed to evaluate the safety and efficacy of ricolinostat for painful diabetic neuropathy.

Enroll Now

If you are human, leave this field blank.

First Name

Last Name

Phone

Address

City

State/Province

Zip/Postal

Name of Primary Care Physician *

If you don't have a primary care physician, just type "Do not have a primary care physician"

Study Name *